Actinobac Biomed, Inc.

Actinobac Biomed, Inc.

Actinobac Biomed, Inc.

Actinobac Biomed focuses on the development of pharmaceutical technologiesderived from agents that target LFA-1.
Type
B2b
Founded
2009
Raised
$5M
Follow us
Alexa global traffic share
Latest funding Show all
$4,400,000
Venture capital - 2017
Kairos Venture Investments
$100,000
Venture capital (Series B) - 2013
Team Size
2
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Actinobac Biomed, Inc. makes some noise.